Literature DB >> 6088402

Type-I HTLV antibody in urban and rural Ghana, West Africa.

R J Biggar, C Saxinger, C Gardiner, W E Collins, P H Levine, J W Clark, F K Nkrumah, W A Blattner.   

Abstract

The prevalence of antibodies against the newly described human T-cell lymphoma virus, type I (HTLV-I) in two communities in Ghana, West Africa, is described. There was no difference by community (urban, 3.6% and rural, 4.0%). Prevalence increased with age, being 5.9% among persons greater than 10 years old, but did not differ by sex. There was no difference when data were analysed by housing status or crowding. Non-confirmed reactions in the assay system were frequent and correlated with both prevalence and titer of antibody against malaria. Possible explanations include vector-borne transmission like that of malaria, but the relationship is more probably due to a polyclonal stimulation of B cells, enhancing the potential for detecting reactivity in the assay. Because assay systems vary and because most laboratories do not routinely use a confirmation assay, results presented by different groups must be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088402     DOI: 10.1002/ijc.2910340212

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  HTLV-I infection in French West Indies: a case-control study.

Authors:  N Frery; M Chavance; I Valette; L Schaffar; C Neisson-Vernant; J Jouannelle; N Monplaisir
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 2.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 3.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

4.  HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia.

Authors:  M Yamashita; A Achiron; T Miura; J Takehisa; E Ido; T Igarashi; K Ibuki; M Osame; S Sonoda; E Melamed
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.

Authors:  R J Biggar; M Melbye; L Kestens; M de Feyter; C Saxinger; A J Bodner; L Paluko; W A Blattner; P L Gigase
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16

6.  Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.

Authors:  W A Blattner; A Nomura; J W Clark; G Y Ho; Y Nakao; R Gallo; M Robert-Guroff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.

Authors:  Saliou Diop; Sara Calattini; Julienne Abah-Dakou; Doudou Thiam; Lamine Diakhaté; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

8.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

9.  Prevalence of blood-borne infectious diseases in blood donors in Ghana.

Authors:  William Ampofo; Nicholas Nii-Trebi; Justina Ansah; Kenji Abe; Hideo Naito; Simeon Aidoo; Victor Nuvor; James Brandful; Naoki Yamamoto; David Ofori-Adjei; Koichi Ishikawa
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background.

Authors:  T Miura; T Fukunaga; T Igarashi; M Yamashita; E Ido; S Funahashi; T Ishida; K Washio; S Ueda; K Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.